Advertisement
Screener

Neogen Corporation (NEOG) Current Income Tax Expense (Benefit)

2.2 / 5 stars · 53/120 Roast Me

Neogen Corporation Current Income Tax Expense (Benefit)

Neogen Corporation (NEOG) reported Current Income Tax Expense (Benefit) of $23.20 million for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-30.

Financial Statements › Expense Statement › Income Tax

us-gaap:CurrentIncomeTaxExpenseBenefit · last filed 2026-07-30

  • Neogen Corporation current income tax expense (benefit) for fiscal 2026 was $23.20M, a 47.77% increase from fiscal 2025.
  • Neogen Corporation current income tax expense (benefit) for fiscal 2025 was $15.70M, a 36.18% decline from fiscal 2024.
  • Neogen Corporation current income tax expense (benefit) for fiscal 2024 was $24.60M, a 22.64% increase from fiscal 2023.
  • Neogen Corporation current income tax expense (benefit) for fiscal 2023 was $20.06M, a 24.37% increase from fiscal 2022.
Period endCurrent Income Tax Expense (Benefit) 12 monthCurrent Income Tax Expense (Benefit) 12 month as first filed
2026-05-31$23.20M
10-K · filed 2026-07-30
2025-05-31$15.70M
10-K · filed 2026-07-30
$15.70M
10-K · filed 2025-07-30
2024-05-31$24.60M
10-K · filed 2026-07-30
$24.60M
10-K · filed 2024-07-30
2023-05-31$20.06M
10-K · filed 2025-07-30
2022-05-31$16.13M
10-K · filed 2024-07-30
2021-05-31$13.93M
10-K · filed 2023-08-15
2020-05-31$10.89M
10-K · filed 2022-07-27

Similar stocks

Stock NameCountryMarket CapPE Ratio
Celldex Therapeutics, Inc. (CLDX)United States$2.471B-9.72
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
BIOMERICA INC (BMRA)United States$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93